연구성과로 돌아가기

2020 연구자 정보 (18 / 997)

※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Author Name 제1저자 여부 교신저자 여부 Address ResearcherID ORCID Paper Title WoS Edition 최상위 JCR(%) WoS Category Related Email
Tak, Won Young
(Tak, WY)
Kyungpook Natl Univ, Sch Med, Internal Med, Daegu, South Korea
Kyungpook Natl Univ, Dept Internal Med, Daegu, South Korea
Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Internal Med, 130 Dongdeok Ro, Daegu 41944, South Korea
Kyungpook Natl Univ, Sch Med, Dept Internal Med, 680 Gukchaebosang Ro, Daegu 41944, South Korea
Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Dept Internal Med, Sch Med, Daegu, South Korea
Kyungpook Natl Univ Hosp, Dept Internal Med, Daegu 41944, South Korea
Kyungpook Natl Univ, Dept Internal Med, Coll Med, Daegu, South Korea
Kyungpook Natl Univ, Sch Med, Dept Internal Med, Daegu, South Korea
Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Internal Med, Daegu 41944, South Korea
Kyungpook Natl Univ Hosp, Dept Internal Med, 130 Dongdeok Ro, Daegu 41944, South Korea
Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Internal Med, Daegu, South Korea
Kyungpook Natl Univ, Dept Internal Med, Sch Med, Daegu 41944, South Korea
Kyungpook Natl Univ Hosp, Dept Internal Med, Daegu, South Korea
Daegu Gyeongbuk Liver Study Grp, Daegu, South Korea
Kyungpook Natl Univ, Dept Internal Med, Sch Med, Daegu, South Korea
Kyungpook Natl Univ, Sch Med, Daegu, South Korea
Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Daegu, South Korea
Kyungpook Natl Univ, Daegu, South Korea
Kyungpook Natl Univ, Coll Med, Daegu, South Korea
AAE-8050-2019
T-8521-2019
Kim, Jin Hyoung
Kim, Young
0000-0002-1914-5141
Tak, Won Young
[JCR상위 1.6] The association with low skeletal muscle mass and carotid atherosclerosis in patients with non-alcoholic fatty liver disease
[JCR상위 1.6] Guideline change for antiviral therapy reduced the risk of HBV-related HCC development among cirrhotic patients in South Korea
[JCR상위 38.6] Treatment Outcomes and Prognostic Factors of Acute variceal Bleeding in Patients with Hepatocellular Carcinoma
Percutaneous portal vein embolization for intractable hepatic biloma after radiofrequency ablation
[JCR상위 1.6] Long interspersed nuclear element-1 (line-1) hypomethylation is associated with poor outcomes via the activation of ST18 in human hepatocellular carcinoma
[JCR상위 1.6] Identification of PD-L1-expressing exosome-derived microRNAs in human hepatocellular carcinoma
[JCR상위 23.6] Examining Liver Cancer Patients and a High-Risk Group in a Vulnerable Area: An Experience from the Ulleung Liver Cancer Prevention and Management Project
[JCR상위 1.6] Validation of diagnostic usefulness of the spot urine Na/K ratio for replacement of 24-hour urine NA excretion in cirrhotic patients with ascites
[JCR상위 54.8] Changes in Characteristics of Patients with Liver Cirrhosis Visiting a Tertiary Hospital over 15 Years: a Retrospective Multi-Center Study in Korea
[JCR상위 37.2] Expression of the Long Noncoding RNA GAS5 Correlates with Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease
[JCR상위 8.2] Validation of the CAMD Score in Patients With Chronic Hepatitis B Virus Infection Receiving Antiviral Therapy
[JCR상위 28.5] Plasma Long Noncoding RNA LeXis is a Potential Diagnostic Marker for Non-Alcoholic Steatohepatitis
[JCR상위 21.9] Hepatocellular Carcinoma Risk Steadily Persists over Time Despite Long-Term Antiviral Therapy for Hepatitis B:A Multicenter Study
[JCR상위 38.0] Fibrosis-4 index as a predictor for mortality in hospitalised patients with COVID-19: a retrospective multicentre cohort study
[JCR상위 43.6] A multi-centre study of trends in hepatitis B virus-related hepatocellular carcinoma risk over time during long-term entecavir therapy
[JCR상위 7.8] Severity and Consolidation Quantification of COVID-19 From CT Images Using Deep Learning Based on Hybrid Weak Labels
[JCR상위 24.5] Clinical outcomes of coronavirus disease 2019 in patients with pre-existing liver diseases: A multicenter study in South Korea
[JCR상위 24.5] Entecavir plus tenofovir vs. lamivudine/telbivudine plus adefovir in chronic hepatitis B patients with prior suboptimal response
[JCR상위 4.5] Extremely low risk of hepatocellular carcinoma development in patients with chronic hepatitis B in immune-tolerant phase
[JCR상위 43.6] Predictive score for hepatocellular carcinoma after hepatitis B e antigen loss in patients treated with entecavir or tenofovir
[JCR상위 1.5] Subsequent anticancer procedures following first-line lenvatinib (LEN): A post hoc analysis from the phase III REFLECT study in unresectable hepatocellular carcinoma (uHCC)
[JCR상위 4.9] Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in virologically suppressed patients with chronic hepatitis B: a randomised, double-blind, phase 3, multicentre non-inferiority study
[JCR상위 18.8] Effects of Branched-Chain Amino Acid (BCAA) Supplementation on the Progression of Advanced Liver Disease: A Korean Nationwide, Multicenter, Prospective, Observational, Cohort Study
[JCR상위 7.1] Effects of Subsequent Systemic Anticancer Medication Following First-Line Lenvatinib: A Post Hoc Responder Analysis from the Phase 3 REFLECT Study in Unresectable Hepatocellular Carcinoma
[JCR상위 1.6] Incidence and risk factors for cardiovascular events in patients with advanced fibrosis due to non-alcoholic steatohepatitis: data from the phase 3 STELLAR trials
[JCR상위 1.6] A phase 3 study comparing switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) with continued TDF treatment in virologically-suppressed patients with chronic hepatitis B (CHB): final week 96 efficacy and safety results
SCIE
ESCI
SCIE;SSCI
1.5 GASTROENTEROLOGY & HEPATOLOGY
RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
ENVIRONMENTAL SCIENCES;PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH
MEDICINE, GENERAL & INTERNAL
GENETICS & HEREDITY
BIOLOGY
ONCOLOGY;PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH
GASTROENTEROLOGY & HEPATOLOGY;INFECTIOUS DISEASES;VIROLOGY
COMPUTER SCIENCE, INFORMATION SYSTEMS;COMPUTER SCIENCE, INTERDISCIPLINARY APPLICATIONS;MATHEMATICAL & COMPUTATIONAL BIOLOGY;MEDICAL INFORMATICS
GASTROENTEROLOGY & HEPATOLOGY;PHARMACOLOGY & PHARMACY
ONCOLOGY
NUTRITION & DIETETICS
GASTROENTEROLOGY & HEPATOLOGY;ONCOLOGY
kmggood111@naver.com;
powerof1004@gmail.com;
psyoung0419@gmail.com;wytak@knu.ac.kr;
specialwent@naver.com;lsyrad@gmail.com;hkryeom@knu.ac.kr;blushain@gmail.com;wytak@knu.ac.kr;magnolia1103@naver.com;yokweon@knu.ac.kr;psyoung0419@gmail.com;deblue00@naver.com;
deblue00@naver.com;
ryudh@cu.ac.kr;yumilee@knu.ac.kr;feliz31@naver.com;wytak@knu.ac.kr;kusmac25@knu.ac.kr;
jangha106@dsmc.or.kr;
chung50@dsmc.or.kr;
one-many@hanmail.net;jihyunlee.knu@gmail.com;aoet111@gmail.com;eunhye7832@naver.com;deblue00@naver.com;magnolia1103@naver.com;hoongir182@naver.com;mong0101@dreamwiz.com;gshyskhk@hanmail.net;yojusi@naver.com;kmggood111@naver.com;wonlee@knu.ac.kr;yokweon@knu.ac.kr;wytak@knu.ac.kr;psyoung0419@gmail.com;gsnrs@naver.com;KeunHur@knu.ac.kr;
beomkkim@yuhs.ac;psyoung0419@gmail.com;
gsnrs@naver.com;med.aurora@gmail.com;magnolia1103@naver.com;deblue00@naver.com;eunhye7832@naver.com;hoongirl82@naver.com;one-many@hanmail.net;cjmdr@knu.ac.kr;gshyskhk@hanmail.net;yojusi@naver.com;kmggood111@naver.com;yokweon@knu.ac.kr;wytak@knu.ac.kr;psyoung@knu.ac.kr;keunhur@knu.ac.kr;psyoung0419@gmail.com;
psyoung0419@gmail.com;chung50@dsmc.or.kr;
dwu6@mgh.harvard.edu;kgong@mgh.harvard.edu;carru@mgh.harvard.edu;fhomayounieh@mgh.harvard.edu;bbizzo@mgh.harvard.edu;varun.buch@mgh.harvard.edu;hren2@mgh.harvard.edu;kkim24@mgh.harvard.edu;nir.neumark@mgh.harvard.edu;pxu3@mgh.harvard.edu;zliu40@mgh.harvard.edu;wfang3@mgh.harvard.edu;nxie@mgh.harvard.edu;wytak@knu.ac.kr;psy@knu.ac.kr;deblue00@naver.com;kmggood111@naver.com;jgpark@ynu.ac.kr;profcarriero@virgilio.it;lucasabamd@gmail.com;mahsami141@gmail.com;rosa.babaei@gmail.com;hadi.karimimobin@gmail.com;sebrahimian@mgh.harvard.edu;idayan@partners.org;mkalra@mgh.harvard.edu;quanzheng@mgh.harvard.edu;
chung50@dsmc.or.kr;kbs9225@cu.ac.kr;psyoung0419@gmail.com;
jheo@pusan.ac.kr;ahnsh@yuhs.ac;
ihkimmd@jbnu.ac.kr;gudwns21@korea.ac.kr;KSUKOREA@yuhs.ac;
gie001@cnuh.co.kr;ksukorea@yuhs.ac;
pietro.lampertico@unimi.it;
gsnrs@naver.com;wytak@knu.ac.kr;psyoung0419@gmail.com;yokweon@knu.ac.kr;chung50@dsmc.or.kr;jangha106@dsmc.or.kr;baesh@catholic.ac.kr;hjlee@med.yu.ac.kr;jyjang@hosp.sch.ac.kr;ktsuk@hallym.ac.kr;zenus1@hanmail.net;jheo@pusan.ac.kr;who54@hanmail.net;magnolia1103@naver.com;deblue00@naver.com;jsleemd@paik.ac.kr;dyk1025@yuhs.ac;midoctor@cnu.ac.kr;sujungil@dongguk.ac.kr;ihkimmd@chonbuk.ac.kr;kmggood111@naver.com;wonlee@knu.ac.kr;
aalsina@tgmg.org;
marianne.camargo2@gilead.com;
Thallinger, Gerhard G.
(Thallinger, GG)
BioTechMed Graz, Omics Ctr Graz, Graz, Austria
Univ Technol, Inst Computat Biotechnol, Graz, Austria
KQV-0539-2024
Thallinger, Gerhard
0000-0002-2864-5404
Thallinger, Gerhard G.
[JCR상위 1.6] FXR-dependent Rubicon induction impairs autophagy in models of human cholestasis SCIE 1.6 GASTROENTEROLOGY & HEPATOLOGY martin.wagner@medunigraz.at;
Thorell, Anders
(Thorell, A)
Ersta Hosp, Danderyd Hosp, Dept Clin Sci, Karolinska Inst, Stockholm, Sweden
Ersta Hosp, Dept Surg, Stockholm, Sweden

0000-0001-7238-1728
Thorell, Anders
[JCR상위 1.6] FXR-dependent Rubicon induction impairs autophagy in models of human cholestasis SCIE 1.6 GASTROENTEROLOGY & HEPATOLOGY martin.wagner@medunigraz.at;
Trauner, Michael
(Trauner, M)
Med Univ Vienna, Dept Med 3, Div Gastroenterol & Hepatol, Vienna, Austria HCH-4032-2022
Trauner, Michael
0000-0002-1275-6425
Trauner, Michael
[JCR상위 1.6] FXR-dependent Rubicon induction impairs autophagy in models of human cholestasis SCIE 1.6 GASTROENTEROLOGY & HEPATOLOGY martin.wagner@medunigraz.at;
Wagner, Martin
(Wagner, M)
교신저자 Med Univ Graz, Div Gastroenterol & Hepatol, Graz, Austria
Med Univ Graz, Res Unit Translat Nucl Receptor Res, Graz, Austria
BioTechMed Graz, Omics Ctr Graz, Graz, Austria


[JCR상위 1.6] FXR-dependent Rubicon induction impairs autophagy in models of human cholestasis SCIE 1.6 GASTROENTEROLOGY & HEPATOLOGY martin.wagner@medunigraz.at;
Xiao, Rui
(Xiao, R)
Baylor Coll Med, Mol & Human Genet, Houston, TX 77030 USA

[JCR상위 1.6] FXR-dependent Rubicon induction impairs autophagy in models of human cholestasis SCIE 1.6 GASTROENTEROLOGY & HEPATOLOGY martin.wagner@medunigraz.at;
Yoon, Jung-Hwan
(Yoon, JH)
Seoul Natl Univ Hosp, Seoul, South Korea
Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea
Seoul Natl Univ Hosp, Liver Res Inst, Seoul, South Korea
J-5563-2012
Yoon, Jung

[JCR상위 1.6] Hepatitis B virus (HBV) surface antigen (HBsAg) inhibition with isis 505358 in chronic hepatitis B (CHB) patients on stable nucleos (t)ide analogue (NA) regimen and in NA -naive CHB patients: phase 2a, randomized, double-blind, placebo-controlled study
[JCR상위 6.0] REVISITING THE IMPACT OF HBEAG-STATUS OF ANTIVIRAL TREATMENT ON RISK OF HEPATOCELLULAR CARCINOMA DEVELOPMENT: A NATIONWIDE MULTICENTER STUDY
SCIE 1.6 GASTROENTEROLOGY & HEPATOLOGY jkwoh@ionisph.com;
Younossi, Zobair M.
(Younossi, ZM)
Inova Fairfax Med Campus, Falls Church, VA USA JRY-9916-2023
Younossi, Zobair M.

[JCR상위 1.6] Incidence and risk factors for cardiovascular events in patients with advanced fibrosis due to non-alcoholic steatohepatitis: data from the phase 3 STELLAR trials SCIE 1.6 GASTROENTEROLOGY & HEPATOLOGY marianne.camargo2@gilead.com;
Yuen, Man-Fung
(Yuen, MF)
제1저자 Univ Hong Kong, Queen Mary Hosp, Hong Kong, Peoples R China C-4466-2009
Yuen, Richard Man Fung

[JCR상위 1.6] Hepatitis B virus (HBV) surface antigen (HBsAg) inhibition with isis 505358 in chronic hepatitis B (CHB) patients on stable nucleos (t)ide analogue (NA) regimen and in NA -naive CHB patients: phase 2a, randomized, double-blind, placebo-controlled study SCIE 1.6 GASTROENTEROLOGY & HEPATOLOGY jkwoh@ionisph.com;
Baik, Ji Sue
(Baik, JS)
제1저자 Dongnam Inst Radiol & Med Sci, Res Ctr, Busan 46033, South Korea
0000-0002-3483-6004
Baik, Jisue
[JCR상위 1.8] Ginsenoside-Rp1 inhibits radiation-induced effects in lipopolysaccharide-stimulated J774A.1 macrophages and suppresses Ched phenotypic variation in CT26 colon cancer cells SCIE 1.8 CHEMISTRY, MEDICINAL;INTEGRATIVE & COMPLEMENTARY MEDICINE mtpark@dirams.re.kr;sdkim@dirams.re.kr;
Cho, H. -J.
(Cho, HJ)
Daegu Fatima Hosp, Fatima Res Inst, Lab Arthrit & Bone Biol, Daegu, South Korea

[JCR상위 1.8] ENDOGENOUSLY EXPRESSED CXC CHEMOKINE RECEPTOR TYPE 7 IS INVOLVED IN INFLAMMATION OF CHONDROCYTE FROM MICE SCIE 1.8 ORTHOPEDICS;RHEUMATOLOGY
Cho, Y.
(Cho, Y)
Ewha Womans Univ, Dept Internal Med, Coll Med, Seoul, South Korea

[JCR상위 1.8] Clinical aspects of severe cutaneous adverse reactions caused by beta-lactam antibiotics: A study from the Korea SCAR Registry SCIE 1.8 ALLERGY;IMMUNOLOGY
Han, Chang-Kyun
(Han, CK)
Korean Ginseng Cooperat, R&D Headquarters, Daejeon 34520, South Korea

[JCR상위 1.8] Adaptogenic effects of Panax ginseng on modulation of cardiovascular functions SCIE 1.8 CHEMISTRY, MEDICINAL;INTEGRATIVE & COMPLEMENTARY MEDICINE shhyun@kgc.co.kr;rheemh@knu.ac.kr;
Han, M. -S.
(Han, MS)
Daegu Fatima Hosp, Fatima Res Inst, Lab Arthrit & Bone Biol, Daegu, South Korea KXR-2750-2024
Han, Moonsu

[JCR상위 1.8] ENDOGENOUSLY EXPRESSED CXC CHEMOKINE RECEPTOR TYPE 7 IS INVOLVED IN INFLAMMATION OF CHONDROCYTE FROM MICE SCIE 1.8 ORTHOPEDICS;RHEUMATOLOGY
Han, S.
(Han, S)
Kyungpook Natl Univ Hosp, Daegu, South Korea

[JCR상위 1.8] ADENOSINE AND GUANOSINE-BASED OLIGONUCLEOTIDE ATTENUATES IL-1β-MEDIATED CATABOLIC PHENOTYPES OF CHONDROCYTES AND SURGICALLY INDUCED OSTEOARTHRITIS PROGRESSION IN MICE
[JCR상위 1.8] BREAKDOWN OF THE EXTRACELLULAR MATRIX RECAPITULATES OSTEOARTHRITIC PHENOTYPES IN 3D-HYDROGEL MODEL: THE VALIDATION OF IN VITRO CELL CULTURE MODEL OF OSTEOARTHRITIS
SCIE 1.8 ORTHOPEDICS;RHEUMATOLOGY
페이지 이동: